| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/25/2008 | CN101205539A Highly pathogenic PRRS virus recombinant plasmid and genetic engineering vaccines |
| 06/25/2008 | CN101205535A Method for providing recombinant baculovirus with polyhedrosis coatings |
| 06/24/2008 | US7390652 Bioreactor comprising device for separating cells from microcarriers; viral particle generation |
| 06/24/2008 | US7390495 Neurovirulent strain of the West Nile virus and uses thereof |
| 06/24/2008 | US7390487 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/19/2008 | WO2008073893A2 Methods for producing an adenovirus type 5 gene transfer vector |
| 06/19/2008 | WO2008073688A2 Improved expression system for recombinant human arginase i |
| 06/19/2008 | WO2008071774A1 Purification process for coat protein of rna bacteriophages |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080145915 Hepatitis C virus vaccine |
| 06/19/2008 | US20080145896 Anti Hiv-I Bacterial and Baculovirus Recombinant Epap-1 |
| 06/19/2008 | US20080145382 (CTLA-4, Cytotoxic T-Lymphocyte Antigen-4); vaccines, feline immunomodulators, antitumor agents; treating feline viral diseases; veterinary medicine |
| 06/19/2008 | US20080145381 Multi-subtype FIV vaccines |
| 06/19/2008 | US20080145339 Modified rolling circle initiator protein for use as therapeutic tool in suppression of viral replication and disorders |
| 06/19/2008 | CA2660038A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 06/18/2008 | EP1932426A1 Gene delivery system and methods of use |
| 06/18/2008 | EP1931383A1 Interleukin-1 conjugates and uses thereof |
| 06/18/2008 | EP1685243B1 Immortalized avian cell lines for virus production |
| 06/18/2008 | EP1115879B1 Retroviral particles protected against complement mediated destruction |
| 06/18/2008 | CN101203613A Method of increasing the function of gland related viral vector |
| 06/18/2008 | CN101203528A Hepatitis-b viral variants with reduced susceptibility to nucleoside analogs and uses thereof |
| 06/18/2008 | CN101200710A Duck plague vaccines and special strains therefor |
| 06/18/2008 | CN101200705A Animal-free cell culture method |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | CA2247336C Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/17/2008 | CA2230655C Chromatographic purification of adenovirus and aav |
| 06/12/2008 | WO2008035169A3 Process for preparing hepatic cells from progenitor cells present in umbilical cord blood |
| 06/12/2008 | US20080139465 Large Scale Preparation of Alpha-1 Proteinase Inhibitor and Use Thereof |
| 06/12/2008 | US20080138861 Viral vector for use as efficient gene transfer and expression tool in genetic engineering |
| 06/12/2008 | US20080138858 Expression System for Recombinant Human Arginase I |
| 06/12/2008 | US20080138848 Microfluidic Device and Method of Using Same |
| 06/12/2008 | US20080138363 Attenuated Chimeric Flavivirus Bearing Attenuated Japanese Encephalitis Virus Gene as Backbone |
| 06/12/2008 | US20080138362 Cell Strain Capable of Being Cultured Without Ingredients Derived From Animals, Method of Producing the Same, Method of Producing Virus Using the Same, and Method of Producing Vaccine |
| 06/12/2008 | US20080138318 Compositions Comprising Viruses and Methods for Concentrating Virus Preparations |
| 06/11/2008 | EP1930418A1 Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| 06/11/2008 | EP1930417A1 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 06/11/2008 | EP1930416A1 Novel recombinant human hepatitis c virus-like particle and method for producing the same |
| 06/11/2008 | EP1930026A1 A method for generating birnavirus from synthetic RNA transcripts |
| 06/11/2008 | EP1301637B1 Dna vaccines encoding hiv accessory proteins |
| 06/11/2008 | CN101198692A HIV vaccine |
| 06/11/2008 | CN101198339A Highly attenuated pox virus strains, method for the production thereof and the use thereof as paramunity inducers or for producing vector vaccines |
| 06/11/2008 | CN100393872C Reproduction of defect type Tiantan strain vaccinia virus |
| 06/10/2008 | US7384774 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
| 06/10/2008 | US7384747 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 06/10/2008 | US7384644 Modified Vaccinia Ankara virus variant |
| 06/10/2008 | US7384627 Antitumor agents with the use of HSV |
| 06/05/2008 | WO2007066188A3 Marked bovine viral diarrhea virus vaccines |
| 06/05/2008 | US20080131928 Uniform-sized SV40 viral agent composed of viral protein and particle formation acceleration factor for use in drug delivery and gene therapy |
| 06/05/2008 | US20080131459 Vaccines, diagnostic agents; expression vectors for heterologous genes; deletion mutants, pseudorevertants, transfectants |
| 06/05/2008 | US20080131403 Recombinant Adeno-Associated Virus Expressing human Antisense Gene Cyp2j2 and Its Preparation Methods |
| 06/05/2008 | CA2671264A1 Improved immunoglobulin libraries |
| 06/04/2008 | EP1927660A2 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions |
| 06/04/2008 | CN101194165A Method for porcine circovirus production and assays for monitoring production |
| 06/04/2008 | CN101194012A Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
| 06/04/2008 | CN101191125A Chick embryo allantoic cavity inoculation method for increasing avian influenza virus separation rate |
| 06/04/2008 | CN101191046A Simple egg inoculation sealing method |
| 06/04/2008 | CN100392087C Flavivirus vaccine delivery system |
| 06/04/2008 | CN100392084C Recombinant adenovirus containing codon optimized type IIPV16L1 gene |
| 06/04/2008 | CN100392083C DNA encoding ovine adenovirus (OAV 287) and its use as a viral vector |
| 06/03/2008 | CA2558659C Genetically engineered canary poxvirus-based vaccine strain |
| 06/03/2008 | CA2203809C Recombinant adenovirus and methods of use thereof |
| 06/03/2008 | CA2200148C Use of structured depth filters for virus removal |
| 05/29/2008 | WO2008063310A2 Use of cell surface displays in yeast cell catalyst supports |
| 05/29/2008 | WO2008030602A3 Stabilization of biological materials through inactivation of metalloenzymes |
| 05/29/2008 | US20080125444 Acyclic oximyl hepatitis c protease inhibitors |
| 05/29/2008 | US20080124803 cDNA Corresponding to the antigenome of nonsegmented negative stranded RNA viruses and process for the production of such viruses |
| 05/29/2008 | US20080124360 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124356 Keratinocyte Culturing Method and the Use Thereof |
| 05/29/2008 | US20080124305 Methods for isolating phage and for controlling microorganism populations with the phage |
| 05/29/2008 | US20080124304 Using vector transformation to generate cells which produce viral particle for use in medical genetics |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | CA2667705A1 Suppression of mitochondrial oxidative stress |
| 05/28/2008 | EP1925662A1 Recombinant Poxvirus-Cytomegalovirus Compositions and uses |
| 05/28/2008 | EP1924281A2 Modified influenza virus for monitoring and improving vaccine efficiency |
| 05/28/2008 | EP1420819B1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 05/28/2008 | EP1373536B1 Lentiviral packaging constructs |
| 05/28/2008 | EP0953647B1 Method for preparing retrovirus vector for gene therapy |
| 05/28/2008 | EP0811069B1 Chimeric adenoviral fiber protein and methods of using same |
| 05/28/2008 | CN101189254A 疫苗 Vaccine |
| 05/28/2008 | CN101186902A Pseudorabies virus SA215, pseudorabies virus polygene deletion bacterin and preparation method thereof |
| 05/28/2008 | CN101186637A Method for inhibiting influenza virus infection and medicament thereof |
| 05/28/2008 | CN100390292C Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/27/2008 | US7378515 Synthetic gagpol genes and their uses |
| 05/27/2008 | US7378498 Protein encoded by a nucleic acid |
| 05/27/2008 | US7378265 Such as adenoviruses with tri-n-butyl phosphate solvent; replication-defective |
| 05/27/2008 | US7378086 Replication-defective retroviral vector for use as gene transfer and expression tool in avian transgenics; bioreactor and heterologous protein expression; tissue engineering |
| 05/27/2008 | CA2322616C A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 05/22/2008 | WO2008058396A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | WO2008058369A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | WO2007132480B1 A composition useful as a vaccine |
| 05/22/2008 | US20080118970 Methods of adenovirus purification |
| 05/22/2008 | US20080118969 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/22/2008 | US20080118956 Viral Particles Containing An Alphavirus-Derived Vector And Method For Preparing Said Viral Particle |
| 05/22/2008 | US20080118528 Expressing a construct comprising the prM and E genes in a baculoviral expression cassette and cloned under the control of a promoter in insect cells; culturing; separation by lysis; diagnostic and therapeutic vaccines; vaccination |
| 05/22/2008 | US20080118494 Transgenic lymphocyte for use as model to screen viral activating and inhibitory agenys; viricides and vaccines |
| 05/22/2008 | US20080118491 Xylanase gene sequences from the genomic DNA of unpurified rumen microorganisms |
| 05/22/2008 | US20080118470 Recombinant viral vector comprising adenoviral backbone and coding colony stimulating factor for selective killing of neoplastic cells |
| 05/22/2008 | US20080118468 Novel Salmonella Bacteriophage and Uses Thereof |
| 05/22/2008 | CA2669485A1 Papaya mosaic virus-based vaccines for influenza |